Walden Group Healthcare M&A Blog

  • Teladoc Health to Buy Livongo in $18.5b Mega-Deal

    8/12/2020
    Teladoc (NYSE: TDOC), a $553.3m telemedicine provider, is buying Livongo (Nasdaq: LVGO), a $170.2m digital health and virtual diabetes coaching company, in an $18.5b merger, to create a company with a combined $1.3b in revenue in 2020, up 85% YOY.  This is the largest digital health deal in history, ringing in at a purchase price for Livongo at...
    Read More
  • Creo Medical Acquires Albyn Medical for $29.3m

    8/3/2020
    Creo Medical, a UK-based developer of endoscopic microwave and radiofrequency ablation technologies, is acquiring Albyn Medical, a Spain-based manufacturer of branded and third-party gastroenterology, urology and endoscopy products including biopsy forceps, snares, catheters, tubes and valves. The acquisition expands Creo’s GI product suite and...
    Read More
  • Nexelis Acquires Integrated Bioanalytical CRO AIT Bioscience

    7/27/2020
    Nexelis, a Canada-based provider of advanced assay development and laboratory testing services in infectious, oncologic, and metabolic diseases and an Ampersand Capital Partners portfolio company, has acquired AIT Bioscience, LLC, a U.S.-based integrated bioanalytical laboratory with liquid chromatography–mass spectrometry (LC-MS) and...
    Read More
  • Medtronic to Acquire Medicrea

    7/20/2020
    Medtronic plc, a major, $28.9b medical device maker of cardiovascular, orthopedic, spinal and other surgical devices, is buying Medicrea, a France-based developer of patient-specific, 3D-printed titanium spinal implants and related workflow software that helps surgeons use predictive modeling to digitally reconstruct a patient’s spine profile....
    Read More
  • LGC Limited Purchases The Native Antigen Company

    7/15/2020
    UK-based producer of diagnostic reagents LGC has purchased The Native Antigen Company (NAC), a UK-based supplier of recombinant viral and bacterial antigens, antibodies and immunoassays. NAC was among the first companies to offer antigens for SARS-COV-2 on a global scale.  The deal adds >60 viral and infectious disease products to...
    Read More